An accurate history reduces risk.
By Fidelindo Lim, DNP, CCRN, and Nick Deuz, BSN, RN
Yi Rong Huang, a 55-year-old man who speaks only Chinese, comes to the emergency department (ED) for nonradiating substernal chest pain. His electrocardiogram (ECG) shows a sinus rhythm with no ST changes; his vital signs are blood pressure (BP) 160/92 mm Hg, heart rate (HR) 95 to 100 beats/minute (bpm), respiratory rate (RR) 22 breaths/minute, oxygen saturation (O2 sat) 94% on room air, and temperature 100.4° F (38° C). Bilateral rhonchi are noted on auscultation. His allergies and medications are unknown.
History and assessment
Call for help
The interpreter arrives in the telemetry unit, and Peter fills her in. Shortly after Mr. Huang is connected to the telemetry monitor, Peter hears him wheezing loudly. On auscultation, he notes diffuse wheezing in all lung fields. Mr. Huang is pale, diaphoretic, and lethargic. His vital signs are BP 168/90 mm Hg, HR 100 to 110 bpm with atrial fibrillation, RR 32 breaths/minute, and his O2 sat is 90%. Concerned about these sudden clinical changes, Peter calls for the rapid response team (RRT).
On the scene
After Peter updates the RRT leader, a 12-lead ECG, a portable chest X-ray, and an arterial blood gas (ABG) are performed. Mr. Huang is given albuterol nebulizer
(5 mg/mL in 3 mL saline) and is placed on a 100% nonrebreather mask. His vital signs are monitored every 5 minutes. Mr. Huang’s ABGs reveal compensated respiratory alkalosis, and his ECG shows a new onset of atrial fibrillation with a rate of 120 bpm.
Mr. Huang’s English-speaking daughter arrives, and she explains that he has a history of asthma, GI reflux disease, and hypertension. Mr. Huang is given one dose of diltiazem 20 mg I.V. push. His atrial fibrillation soon converts to sinus rhythm between 80 to 85 bpm. A second dose of albuterol nebulizer is given, and aspirin and carvedilol are discontinued. Mr. Huang is given one dose of diphenhydramine 50 mg I.V. push. A repeat chest X-ray doesn’t reveal any new changes.
Outcome
Mr. Huang is placed on albuterol and ipratropium nebulizers every 6 hours. (His practitioner chose not to prescribe corticosteroids.) His wheezing improves and his O2 sat is 97%. Mr. Huang’s regular medications (lisinopril, fluticasone/salmeterol, and famotidine) are resumed, and a cardiologist is consulted. He is discharged home 2 days later on oral levofloxacin.
Education and follow up
Current teaching focuses on preventing asthma attacks, which can be life-threatening. Asthma triggers include medications such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and beta blockers. More than 25% of adults with asthma are hypersensitive to aspirin.
Mr. Huang was given aspirin and carvedilol (a non-cardioselective beta blocker) immediately before his asthma attack. Aspirin and other NSAIDs block cyclooxygenase 1, which is responsible for synthesizing prostaglandin E2, a potent bronchodilator, resulting in asthma exacerbation by constricting the airway and increasing oxygen resistance through the bronchioles. Combining the aspirin with carvedilol created a synergistic interaction that intensified Mr. Huang’s bronchoconstriction. Normally, carvedilol would be avoided in a patient with asthma.
Before discharge, Mr. Huang is given an asthma action plan in Chinese. By acting quickly, Peter was able to mitigate the negative effects of Mr. Huang’s condition.
Fidelindo Lim is a clinical assistant professor at New York University Rory Meyers College of Nursing in New York, New York. Nick Deuz is a staff nurse at Children’s Hospital at Montefiore in the pediatric hematology/oncology unit in New York, New York.
Selected references
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2017.
Kowalski ML, Makowska JS. Seven steps to the diagnosis of NSAIDs hypersensitivity: How to apply a new classification in real practice? Allergy Asthma Immunol Res. 2015;7(4):312-20.
National Heart, Lung, and Blood Institute. Asthma Care Quick Reference: Diagnosing and Managing Asthma. 2012.
Wieczfinska J, Kacprzak D, Pospiech K, et al. The whole-genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge. Respir Res. 2015;16:147.
ant1-Rapid Response-1214